Why is Valiant Laborato falling/rising?

As of 17-Jul, Valiant Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 117.05, which reflects a decrease of Rs 3.7 or 3.06%. Today's price summary indicates that the stock opened with a gain of 2.03% but has since fallen, marking a trend reversal after two consecutive days of gains. The stock reached an intraday high of Rs 123.6 but also touched a low of Rs 115, indicating significant volatility. Despite a recent rise in investor participation, with delivery volume increasing by 495.68% against the 5-day average, the stock has underperformed its sector by 3.48%. Over the past year, Valiant Laboratories has generated a return of -17.89%, significantly underperforming the benchmark Sensex, which has gained 1.91% during the same period.
The broader market context shows that while Valiant Laboratories has had some positive results in the recent quarter, including higher net sales and profit after tax, the long-term fundamentals remain weak. The company has a poor average return on equity of 0% and has shown a concerning decline in net sales and operating profit over the past five years. Additionally, the stock is considered risky due to negative EBITDA and a weak ability to service its debt, as evidenced by a poor EBIT to interest ratio. The lack of investment from domestic mutual funds, which hold 0% of the company, suggests a lack of confidence in the stock's valuation or business prospects. Overall, these factors contribute to the stock's recent downward movement and consistent underperformance against the benchmark.